nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CYP1A1—polycystic ovary syndrome	0.474	1	CbGaD
Arsenic trioxide—CCND1—embryo—polycystic ovary syndrome	0.00455	0.0276	CbGeAlD
Arsenic trioxide—MAPK1—embryo—polycystic ovary syndrome	0.00383	0.0232	CbGeAlD
Arsenic trioxide—CCND1—adrenal cortex—polycystic ovary syndrome	0.00373	0.0226	CbGeAlD
Arsenic trioxide—MAPK3—embryo—polycystic ovary syndrome	0.00339	0.0206	CbGeAlD
Arsenic trioxide—CCND1—endometrium—polycystic ovary syndrome	0.00333	0.0202	CbGeAlD
Arsenic trioxide—AKT1—embryo—polycystic ovary syndrome	0.0032	0.0194	CbGeAlD
Arsenic trioxide—CCND1—uterus—polycystic ovary syndrome	0.00307	0.0186	CbGeAlD
Arsenic trioxide—CCND1—pituitary gland—polycystic ovary syndrome	0.00301	0.0183	CbGeAlD
Arsenic trioxide—CCND1—adipose tissue—polycystic ovary syndrome	0.003	0.0182	CbGeAlD
Arsenic trioxide—TXNRD1—adrenal cortex—polycystic ovary syndrome	0.00292	0.0177	CbGeAlD
Arsenic trioxide—JUN—embryo—polycystic ovary syndrome	0.00278	0.0169	CbGeAlD
Arsenic trioxide—MAPK3—adrenal cortex—polycystic ovary syndrome	0.00278	0.0169	CbGeAlD
Arsenic trioxide—IKBKB—embryo—polycystic ovary syndrome	0.00277	0.0168	CbGeAlD
Arsenic trioxide—CCND1—adrenal gland—polycystic ovary syndrome	0.00269	0.0163	CbGeAlD
Arsenic trioxide—AKT1—adrenal cortex—polycystic ovary syndrome	0.00262	0.0159	CbGeAlD
Arsenic trioxide—TXNRD1—endometrium—polycystic ovary syndrome	0.00261	0.0158	CbGeAlD
Arsenic trioxide—MAPK1—uterus—polycystic ovary syndrome	0.00258	0.0157	CbGeAlD
Arsenic trioxide—MAPK1—adipose tissue—polycystic ovary syndrome	0.00253	0.0153	CbGeAlD
Arsenic trioxide—CCND1—female gonad—polycystic ovary syndrome	0.00251	0.0152	CbGeAlD
Arsenic trioxide—CCND1—vagina—polycystic ovary syndrome	0.00249	0.0151	CbGeAlD
Arsenic trioxide—MAPK3—endometrium—polycystic ovary syndrome	0.00248	0.015	CbGeAlD
Arsenic trioxide—TXNRD1—uterus—polycystic ovary syndrome	0.00241	0.0146	CbGeAlD
Arsenic trioxide—CYP3A4—urine—polycystic ovary syndrome	0.00238	0.0144	CbGeAlD
Arsenic trioxide—TXNRD1—pituitary gland—polycystic ovary syndrome	0.00236	0.0143	CbGeAlD
Arsenic trioxide—TXNRD1—adipose tissue—polycystic ovary syndrome	0.00235	0.0143	CbGeAlD
Arsenic trioxide—AKT1—endometrium—polycystic ovary syndrome	0.00234	0.0142	CbGeAlD
Arsenic trioxide—CCND1—endocrine gland—polycystic ovary syndrome	0.00233	0.0141	CbGeAlD
Arsenic trioxide—MAPK3—uterus—polycystic ovary syndrome	0.00229	0.0139	CbGeAlD
Arsenic trioxide—JUN—adrenal cortex—polycystic ovary syndrome	0.00228	0.0138	CbGeAlD
Arsenic trioxide—MAPK1—adrenal gland—polycystic ovary syndrome	0.00227	0.0137	CbGeAlD
Arsenic trioxide—MAPK3—pituitary gland—polycystic ovary syndrome	0.00225	0.0136	CbGeAlD
Arsenic trioxide—MAPK3—adipose tissue—polycystic ovary syndrome	0.00224	0.0136	CbGeAlD
Arsenic trioxide—AKT1—uterus—polycystic ovary syndrome	0.00216	0.0131	CbGeAlD
Arsenic trioxide—AKT1—pituitary gland—polycystic ovary syndrome	0.00212	0.0128	CbGeAlD
Arsenic trioxide—MAPK1—female gonad—polycystic ovary syndrome	0.00211	0.0128	CbGeAlD
Arsenic trioxide—TXNRD1—adrenal gland—polycystic ovary syndrome	0.00211	0.0128	CbGeAlD
Arsenic trioxide—AKT1—adipose tissue—polycystic ovary syndrome	0.00211	0.0128	CbGeAlD
Arsenic trioxide—MAPK1—vagina—polycystic ovary syndrome	0.0021	0.0127	CbGeAlD
Arsenic trioxide—JUN—endometrium—polycystic ovary syndrome	0.00204	0.0124	CbGeAlD
Arsenic trioxide—IKBKB—endometrium—polycystic ovary syndrome	0.00203	0.0123	CbGeAlD
Arsenic trioxide—MAPK3—adrenal gland—polycystic ovary syndrome	0.00201	0.0122	CbGeAlD
Arsenic trioxide—TXNRD1—female gonad—polycystic ovary syndrome	0.00197	0.0119	CbGeAlD
Arsenic trioxide—MAPK1—endocrine gland—polycystic ovary syndrome	0.00197	0.0119	CbGeAlD
Arsenic trioxide—TXNRD1—vagina—polycystic ovary syndrome	0.00196	0.0119	CbGeAlD
Arsenic trioxide—AKT1—adrenal gland—polycystic ovary syndrome	0.00189	0.0115	CbGeAlD
Arsenic trioxide—JUN—uterus—polycystic ovary syndrome	0.00188	0.0114	CbGeAlD
Arsenic trioxide—MAPK3—female gonad—polycystic ovary syndrome	0.00187	0.0113	CbGeAlD
Arsenic trioxide—IKBKB—uterus—polycystic ovary syndrome	0.00187	0.0113	CbGeAlD
Arsenic trioxide—MAPK3—vagina—polycystic ovary syndrome	0.00186	0.0113	CbGeAlD
Arsenic trioxide—JUN—pituitary gland—polycystic ovary syndrome	0.00184	0.0112	CbGeAlD
Arsenic trioxide—JUN—adipose tissue—polycystic ovary syndrome	0.00184	0.0111	CbGeAlD
Arsenic trioxide—IKBKB—pituitary gland—polycystic ovary syndrome	0.00183	0.0111	CbGeAlD
Arsenic trioxide—TXNRD1—endocrine gland—polycystic ovary syndrome	0.00183	0.0111	CbGeAlD
Arsenic trioxide—IKBKB—adipose tissue—polycystic ovary syndrome	0.00183	0.0111	CbGeAlD
Arsenic trioxide—AKT1—female gonad—polycystic ovary syndrome	0.00176	0.0107	CbGeAlD
Arsenic trioxide—AKT1—vagina—polycystic ovary syndrome	0.00175	0.0106	CbGeAlD
Arsenic trioxide—MAPK3—endocrine gland—polycystic ovary syndrome	0.00174	0.0105	CbGeAlD
Arsenic trioxide—JUN—adrenal gland—polycystic ovary syndrome	0.00165	0.00999	CbGeAlD
Arsenic trioxide—AKT1—endocrine gland—polycystic ovary syndrome	0.00164	0.00995	CbGeAlD
Arsenic trioxide—IKBKB—adrenal gland—polycystic ovary syndrome	0.00164	0.00994	CbGeAlD
Arsenic trioxide—JUN—female gonad—polycystic ovary syndrome	0.00154	0.00931	CbGeAlD
Arsenic trioxide—IKBKB—female gonad—polycystic ovary syndrome	0.00153	0.00927	CbGeAlD
Arsenic trioxide—JUN—vagina—polycystic ovary syndrome	0.00153	0.00925	CbGeAlD
Arsenic trioxide—IKBKB—vagina—polycystic ovary syndrome	0.00152	0.00921	CbGeAlD
Arsenic trioxide—JUN—endocrine gland—polycystic ovary syndrome	0.00143	0.00866	CbGeAlD
Arsenic trioxide—IKBKB—endocrine gland—polycystic ovary syndrome	0.00142	0.00862	CbGeAlD
Arsenic trioxide—CYP1B1—uterus—polycystic ovary syndrome	0.001	0.00607	CbGeAlD
Arsenic trioxide—CYP1B1—pituitary gland—polycystic ovary syndrome	0.000983	0.00596	CbGeAlD
Arsenic trioxide—CYP1B1—adipose tissue—polycystic ovary syndrome	0.000979	0.00593	CbGeAlD
Arsenic trioxide—ABCC2—adrenal gland—polycystic ovary syndrome	0.000896	0.00544	CbGeAlD
Arsenic trioxide—CYP1B1—adrenal gland—polycystic ovary syndrome	0.000878	0.00532	CbGeAlD
Arsenic trioxide—CYP1B1—female gonad—polycystic ovary syndrome	0.000819	0.00496	CbGeAlD
Arsenic trioxide—ABCC2—endocrine gland—polycystic ovary syndrome	0.000777	0.00471	CbGeAlD
Arsenic trioxide—CYP1B1—endocrine gland—polycystic ovary syndrome	0.000761	0.00462	CbGeAlD
Arsenic trioxide—CYP1A1—uterus—polycystic ovary syndrome	0.000707	0.00429	CbGeAlD
Arsenic trioxide—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000692	0.0042	CbGeAlD
Arsenic trioxide—CYP1A1—female gonad—polycystic ovary syndrome	0.000579	0.00351	CbGeAlD
Arsenic trioxide—CYP1A1—vagina—polycystic ovary syndrome	0.000575	0.00349	CbGeAlD
Arsenic trioxide—ABCB1—embryo—polycystic ovary syndrome	0.000545	0.0033	CbGeAlD
Arsenic trioxide—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000538	0.00326	CbGeAlD
Arsenic trioxide—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000447	0.00271	CbGeAlD
Arsenic trioxide—ABCB1—endometrium—polycystic ovary syndrome	0.000399	0.00242	CbGeAlD
Arsenic trioxide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000395	0.00239	CbGeAlD
Arsenic trioxide—ABCB1—uterus—polycystic ovary syndrome	0.000367	0.00223	CbGeAlD
Arsenic trioxide—ABCB1—pituitary gland—polycystic ovary syndrome	0.000361	0.00219	CbGeAlD
Arsenic trioxide—ABCB1—adipose tissue—polycystic ovary syndrome	0.000359	0.00218	CbGeAlD
Arsenic trioxide—ABCB1—adrenal gland—polycystic ovary syndrome	0.000322	0.00195	CbGeAlD
Arsenic trioxide—ABCB1—female gonad—polycystic ovary syndrome	0.000301	0.00182	CbGeAlD
Arsenic trioxide—ABCB1—vagina—polycystic ovary syndrome	0.000299	0.00181	CbGeAlD
Arsenic trioxide—ABCB1—endocrine gland—polycystic ovary syndrome	0.00028	0.00169	CbGeAlD
Arsenic trioxide—AKT1—Disease—MTHFR—polycystic ovary syndrome	1.06e-05	2.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IRS2—polycystic ovary syndrome	1.06e-05	2.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CRP—polycystic ovary syndrome	1.06e-05	2.93e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GNAS—polycystic ovary syndrome	1.05e-05	2.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—IL6—polycystic ovary syndrome	1.05e-05	2.91e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NGFR—polycystic ovary syndrome	1.05e-05	2.91e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.05e-05	2.9e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.04e-05	2.89e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—SLC2A4—polycystic ovary syndrome	1.04e-05	2.89e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PRL—polycystic ovary syndrome	1.04e-05	2.88e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—HSD3B2—polycystic ovary syndrome	1.04e-05	2.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.04e-05	2.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—VEGFA—polycystic ovary syndrome	1.03e-05	2.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MTHFR—polycystic ovary syndrome	1.03e-05	2.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—VEGFA—polycystic ovary syndrome	1.01e-05	2.81e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PLAT—polycystic ovary syndrome	1.01e-05	2.8e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—GHRL—polycystic ovary syndrome	1.01e-05	2.8e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NGFR—polycystic ovary syndrome	1.01e-05	2.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ATF1—polycystic ovary syndrome	1.01e-05	2.79e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IRS2—polycystic ovary syndrome	1.01e-05	2.79e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AKR1C1—polycystic ovary syndrome	1.01e-05	2.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CRP—polycystic ovary syndrome	1.01e-05	2.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IRS2—polycystic ovary syndrome	1.01e-05	2.79e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—POMC—polycystic ovary syndrome	1e-05	2.78e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—NCOR1—polycystic ovary syndrome	1e-05	2.78e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—IL6—polycystic ovary syndrome	1e-05	2.77e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PRL—polycystic ovary syndrome	1e-05	2.77e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IRS1—polycystic ovary syndrome	9.92e-06	2.74e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.89e-06	2.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.85e-06	2.73e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CYP19A1—polycystic ovary syndrome	9.81e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NGFR—polycystic ovary syndrome	9.8e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	9.8e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MTHFR—polycystic ovary syndrome	9.77e-06	2.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IRS2—polycystic ovary syndrome	9.77e-06	2.7e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	9.77e-06	2.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—POMC—polycystic ovary syndrome	9.74e-06	2.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PRL—polycystic ovary syndrome	9.71e-06	2.69e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ATF1—polycystic ovary syndrome	9.67e-06	2.67e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.65e-06	2.67e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IRS2—polycystic ovary syndrome	9.64e-06	2.67e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CRP—polycystic ovary syndrome	9.64e-06	2.67e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IRS1—polycystic ovary syndrome	9.53e-06	2.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CYP1A1—polycystic ovary syndrome	9.51e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.5e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.43e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.36e-06	2.59e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NGFR—polycystic ovary syndrome	9.33e-06	2.58e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	9.32e-06	2.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IRS2—polycystic ovary syndrome	9.3e-06	2.57e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	9.27e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—POMC—polycystic ovary syndrome	9.27e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—PPARG—polycystic ovary syndrome	9.25e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PRL—polycystic ovary syndrome	9.24e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IRS1—polycystic ovary syndrome	9.24e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.22e-06	2.55e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	9.2e-06	2.54e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—AKT2—polycystic ovary syndrome	9.18e-06	2.54e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—GNAS—polycystic ovary syndrome	9.17e-06	2.54e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	8.98e-06	2.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—PPARG—polycystic ovary syndrome	8.97e-06	2.48e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NGFR—polycystic ovary syndrome	8.92e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	8.91e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	8.91e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.91e-06	2.46e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—MTHFR—polycystic ovary syndrome	8.87e-06	2.45e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PRL—polycystic ovary syndrome	8.84e-06	2.45e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—AKT2—polycystic ovary syndrome	8.82e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.81e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IRS1—polycystic ovary syndrome	8.8e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IRS1—polycystic ovary syndrome	8.79e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.77e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GNAS—polycystic ovary syndrome	8.76e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.74e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	8.66e-06	2.39e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NRG1—polycystic ovary syndrome	8.57e-06	2.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—AKT2—polycystic ovary syndrome	8.55e-06	2.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—GNAS—polycystic ovary syndrome	8.54e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IRS1—polycystic ovary syndrome	8.53e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—LHB—polycystic ovary syndrome	8.5e-06	2.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—INS—polycystic ovary syndrome	8.42e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IRS1—polycystic ovary syndrome	8.41e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.39e-06	2.32e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.39e-06	2.32e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—NCOR1—polycystic ovary syndrome	8.34e-06	2.31e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—SERPINE1—polycystic ovary syndrome	8.33e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	8.32e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	8.31e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.27e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NRG1—polycystic ovary syndrome	8.24e-06	2.28e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	8.21e-06	2.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—INS—polycystic ovary syndrome	8.17e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.15e-06	2.26e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—AKT2—polycystic ovary syndrome	8.14e-06	2.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.14e-06	2.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—AKT2—polycystic ovary syndrome	8.14e-06	2.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.13e-06	2.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IRS1—polycystic ovary syndrome	8.12e-06	2.25e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.12e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—SERPINE1—polycystic ovary syndrome	8.08e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	8.05e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—BCL2—polycystic ovary syndrome	8.02e-06	2.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NRG1—polycystic ovary syndrome	7.99e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CYP1A1—polycystic ovary syndrome	7.91e-06	2.19e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—AKT2—polycystic ovary syndrome	7.9e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—AKT2—polycystic ovary syndrome	7.79e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—GNAS—polycystic ovary syndrome	7.78e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—INS—polycystic ovary syndrome	7.77e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	7.76e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—IL6—polycystic ovary syndrome	7.75e-06	2.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.75e-06	2.14e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—SERPINE1—polycystic ovary syndrome	7.74e-06	2.14e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—BCL2—polycystic ovary syndrome	7.7e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	7.64e-06	2.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NRG1—polycystic ovary syndrome	7.6e-06	2.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—IL6—polycystic ovary syndrome	7.52e-06	2.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—AKT2—polycystic ovary syndrome	7.51e-06	2.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—SERPINE1—polycystic ovary syndrome	7.5e-06	2.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—BCL2—polycystic ovary syndrome	7.47e-06	2.07e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	7.47e-06	2.07e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.41e-06	2.05e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	7.41e-06	2.05e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MTHFR—polycystic ovary syndrome	7.37e-06	2.04e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IRS2—polycystic ovary syndrome	7.34e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NRG1—polycystic ovary syndrome	7.27e-06	2.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PPARG—polycystic ovary syndrome	7.19e-06	1.99e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—LEP—polycystic ovary syndrome	7.19e-06	1.99e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	7.17e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—IL6—polycystic ovary syndrome	7.15e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—SERPINE1—polycystic ovary syndrome	7.14e-06	1.98e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IL6—polycystic ovary syndrome	7.12e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—BCL2—polycystic ovary syndrome	7.11e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—POMC—polycystic ovary syndrome	7.09e-06	1.96e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	7.08e-06	1.96e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.06e-06	1.95e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—INS—polycystic ovary syndrome	7.05e-06	1.95e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	6.91e-06	1.91e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—LEP—polycystic ovary syndrome	6.9e-06	1.91e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IL6—polycystic ovary syndrome	6.84e-06	1.89e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IRS2—polycystic ovary syndrome	6.84e-06	1.89e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—BCL2—polycystic ovary syndrome	6.8e-06	1.88e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	6.75e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—LEP—polycystic ovary syndrome	6.7e-06	1.85e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	6.64e-06	1.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IL6—polycystic ovary syndrome	6.64e-06	1.84e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—TH—polycystic ovary syndrome	6.61e-06	1.83e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	6.56e-06	1.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.51e-06	1.8e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	6.43e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IRS1—polycystic ovary syndrome	6.41e-06	1.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—LEP—polycystic ovary syndrome	6.37e-06	1.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IL6—polycystic ovary syndrome	6.32e-06	1.75e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IRS2—polycystic ovary syndrome	6.23e-06	1.72e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	6.2e-06	1.71e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—POMC—polycystic ovary syndrome	6.17e-06	1.71e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.16e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—INS—polycystic ovary syndrome	6.14e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	6.1e-06	1.69e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—LEP—polycystic ovary syndrome	6.1e-06	1.69e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IL6—polycystic ovary syndrome	6.04e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	6.04e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	6.02e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PPARG—polycystic ovary syndrome	5.98e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IRS1—polycystic ovary syndrome	5.97e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IGF1—polycystic ovary syndrome	5.94e-06	1.64e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AKT2—polycystic ovary syndrome	5.93e-06	1.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—POMC—polycystic ovary syndrome	5.93e-06	1.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—INS—polycystic ovary syndrome	5.9e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—POMC—polycystic ovary syndrome	5.9e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—INS—polycystic ovary syndrome	5.86e-06	1.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—POMC—polycystic ovary syndrome	5.75e-06	1.59e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.74e-06	1.59e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—INS—polycystic ovary syndrome	5.72e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.71e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.7e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.68e-06	1.57e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.64e-06	1.56e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—polycystic ovary syndrome	5.61e-06	1.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF1—polycystic ovary syndrome	5.53e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKT2—polycystic ovary syndrome	5.53e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—POMC—polycystic ovary syndrome	5.47e-06	1.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—INS—polycystic ovary syndrome	5.44e-06	1.51e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IRS1—polycystic ovary syndrome	5.44e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.42e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	5.39e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TH—polycystic ovary syndrome	5.28e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.27e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.26e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.26e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	5.24e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—POMC—polycystic ovary syndrome	5.24e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—INS—polycystic ovary syndrome	5.21e-06	1.44e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	5.14e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	5.13e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	5.12e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF1—polycystic ovary syndrome	5.04e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKT2—polycystic ovary syndrome	5.03e-06	1.39e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.96e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	4.83e-06	1.33e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.78e-06	1.32e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.56e-06	1.26e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	4.54e-06	1.26e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.42e-06	1.22e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.36e-06	1.21e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	4.31e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4.26e-06	1.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—polycystic ovary syndrome	4.23e-06	1.17e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—polycystic ovary syndrome	4.15e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	4.1e-06	1.14e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.09e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.04e-06	1.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.03e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—polycystic ovary syndrome	3.99e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	3.89e-06	1.08e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.88e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—polycystic ovary syndrome	3.87e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.82e-06	1.06e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.76e-06	1.04e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.73e-06	1.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	3.68e-06	1.02e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—polycystic ovary syndrome	3.68e-06	1.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—polycystic ovary syndrome	3.68e-06	1.02e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	3.63e-06	1e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	3.63e-06	1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.61e-06	1e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—INS—polycystic ovary syndrome	3.61e-06	9.99e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—polycystic ovary syndrome	3.57e-06	9.87e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—polycystic ovary syndrome	3.52e-06	9.74e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.44e-06	9.51e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—polycystic ovary syndrome	3.4e-06	9.4e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.29e-06	9.1e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.25e-06	8.99e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.16e-06	8.75e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.97e-06	8.22e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.94e-06	8.13e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.9e-06	8.02e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—INS—polycystic ovary syndrome	2.88e-06	7.98e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—polycystic ovary syndrome	2.68e-06	7.42e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.65e-06	7.34e-06	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—polycystic ovary syndrome	2.58e-06	7.13e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.53e-06	6.99e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—polycystic ovary syndrome	2.5e-06	6.91e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.4e-06	6.63e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—polycystic ovary syndrome	2.38e-06	6.58e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—polycystic ovary syndrome	2.28e-06	6.29e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.23e-06	6.18e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.81e-06	5.01e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.79e-06	4.94e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.78e-06	4.92e-06	CbGpPWpGaD
